Related Experiment Video
Updated: Sep 19, 2026
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Design, synthesis, and computational assessment of bis‑oxadiazole ligands targeting α-amylase and α-glucosidase: DFT,
Shoaib Khan1, Tayyiaba Iqbal1, Bibi Nazia Murtaza2
1Department of Chemistry, Abbottabad University of Science and Technology, Abbottabad, Pakistan.
Aim:
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia, mainly due to postprandial glucose elevation. Inhibition of carbohydrate-hydrolyzing enzymes such as α-glucosidase and α-amylase is an effective strategy for its management. This study aimed to design, synthesize, characterize, and evaluate a series of bis-oxadiazole derivatives as potential anti-diabetic agents.
Methods:
The target compounds were synthesized via multistep organic synthesis and structurally confirmed using spectroscopic techniques including FTIR, NMR, and HRMS. The in-vitro anti-diabetic potential was assessed through α-glucosidase and α-amylase inhibition assays. In addition, molecular docking studies were performed to investigate binding interactions and conformational stability within the active sites of both enzymes. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling was also carried out to evaluate drug-likeness and pharmacokinetic properties.
Results:
Among the synthesized derivatives, compound 10 exhibited the most potent activity, showing IC50 values of 1.80 and 2.10 μM against α-amylase and α-glucosidase, respectively, in comparison with the positive control acarbose (IC50 = 5.50 and 5.60 μM, respectively). Compound 10 exhibited the most potent inhibitory activity against both enzymes, showing strong binding affinity and key hydrogen-bonding and hydrophobic interactions in docking studies. The spectroscopic characterization confirmed the successful formation of all target compounds. ADMET analysis indicated favorable pharmacokinetic and toxicity profiles for the most active derivatives.
Conclusion:
The combined experimental and computational results demonstrate significant structure-activity relationships within the bis-oxadiazole scaffold, identifying compound 10 as a promising lead candidate for further optimization as a dual enzyme inhibitor for diabetes management.
Related Concept Videos
00:49Ligand Binding and Linkage
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
02:40Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:19Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...